Cargando…

Adoptive T-cell therapy for Leukemia

Allogeneic stem cell transplantation (alloSCT) is the most robust form of adoptive cellular therapy (ACT) and has been tremendously effective in the treatment of leukemia. It is one of the original forms of cancer immunotherapy and illustrates that lymphocytes can specifically recognize and eliminat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garber, Haven R, Mirza, Asma, Mittendorf, Elizabeth A, Alatrash, Gheath
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452065/ https://www.ncbi.nlm.nih.gov/pubmed/26056592 http://dx.doi.org/10.1186/2052-8426-2-25

Ejemplares similares

Targeting cathepsin G in myeloid leukemia
por: Alatrash, Gheath
Publicado: (2013)

Immune checkpoints: A therapeutic target in triple negative breast cancer
por: Chawla, Akhil, et al.
Publicado: (2014)

Targeting PR1 in myeloid leukemia
por: Alatrash, Gheath, et al.
Publicado: (2017)

CARving the Path to Allogeneic CAR T Cell Therapy in Acute Myeloid Leukemia
por: Pasvolsky, Oren, et al.
Publicado: (2022)

Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target
por: Alatrash, Gheath, et al.
Publicado: (2016)

PR1-Specific T Cells Are Associated with Unmaintained Cytogenetic Remission of Chronic Myelogenous Leukemia After Interferon Withdrawal
por: Kanodia, Shreya, et al.
Publicado: (2010)

Fucosylation enhances activity of cytotoxic T lymphocytes against breast cancer
por: Qiao, Na, et al.
Publicado: (2015)

Cathepsin G Is Expressed by Acute Lymphoblastic Leukemia and Is a Potential Immunotherapeutic Target
por: Khan, Maliha, et al.
Publicado: (2018)

Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
por: Fan, Mingxue, et al.
Publicado: (2017)

A Novel T-Cell Engaging Bi-specific Antibody Targeting the Leukemia Antigen PR1/HLA-A2
por: Herrmann, Amanda C., et al.
Publicado: (2019)

Adoptive Cell Therapy for T-Cell Malignancies
por: Fang, Karen Kai-Lin, et al.
Publicado: (2022)

Trial Watch: Adoptive TCR-Engineered T-Cell Immunotherapy for Acute Myeloid Leukemia
por: Campillo-Davo, Diana, et al.
Publicado: (2021)

Regulatory T Cells in Atherosclerosis: Is Adoptive Cell Therapy Possible?
por: Churov, Alexey V., et al.
Publicado: (2023)

Application of Adoptive T-Cell Therapy Using Tumor Antigen-Specific T-Cell Receptor Gene Transfer for the Treatment of Human Leukemia
por: Ochi, Toshiki, et al.
Publicado: (2010)

Adoptive T-cell therapy for Hodgkin lymphoma
por: Ho, Carrie, et al.
Publicado: (2021)

Challenges and new technologies in adoptive cell therapy
por: Zhang, Pengchao, et al.
Publicado: (2023)

Clinical Pharmacology Perspectives for Adoptive Cell Therapies in Oncology
por: Huang, Weize, et al.
Publicado: (2022)

Immune correlates of melanoma survival in adoptive cell therapy
por: Lee, Agnes Fermin, et al.
Publicado: (2013)

Circulating exosomes carrying an immunosuppressive cargo may interfere with adoptive cell therapies in leukemia
por: Boyiadzis, Michael, et al.
Publicado: (2015)

Adoptive cellular therapy using bone marrow-derived T cells for the treatment of childhood leukemia
por: Gershan, Jill, et al.
Publicado: (2015)

The Past, Present, and Future of Adoptive T Cell Therapy
por: Choi, Donghoon, et al.
Publicado: (2012)

Adoptive T-cell therapy: adverse events and safety switches
por: Tey, Siok-Keen
Publicado: (2014)

Adoptive T cell therapy: Addressing challenges in cancer immunotherapy
por: Yee, Cassian
Publicado: (2005)

Adoptive T-cell therapy for fungal infections in haematology patients
por: Deo, Shivashni S, et al.
Publicado: (2015)

Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy
por: Garcia-Aponte, Oscar Fabian, et al.
Publicado: (2021)

Engineering Strategies to Enhance TCR-Based Adoptive T Cell Therapy
por: Rath, Jan A., et al.
Publicado: (2020)

Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study
por: Reville, Patrick K., et al.
Publicado: (2021)

Promises and challenges of adoptive T-cell therapies for solid tumours
por: Morotti, Matteo, et al.
Publicado: (2021)

Clinical application of adoptive T cell therapy in solid tumors
por: Zang, Yi-Wen, et al.
Publicado: (2014)

Immune cell labelling and tracking: implications for adoptive cell transfer therapies
por: Galli, Filippo, et al.
Publicado: (2021)

Role and Potential of Different T Helper Cell Subsets in Adoptive Cell Therapy
por: Andreu-Sanz, David, et al.
Publicado: (2023)

STING-driven activation of T cells: relevance for the adoptive cell therapy of cancer
por: Richter, Fabian, et al.
Publicado: (2023)

Adoptive cellular therapies: the current landscape
por: Rohaan, Maartje W., et al.
Publicado: (2018)

Leukemia’s Next Top Model? Syngeneic Models to Advance Adoptive Cellular Therapy
por: Zoine, Jaquelyn T., et al.
Publicado: (2022)

Adoptive T Cell Therapy for Solid Tumors: Pathway to Personalized Standard of Care
por: Qin, Shuyang S., et al.
Publicado: (2021)

Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer Cells
por: Kim, Ji Sung, et al.
Publicado: (2015)

Adoption
por: Addis, R. S.
Publicado: (1959)

Molecular Analysis of Elements of Melanoma Insensitivity to TCR-Engineered Adoptive Cell Therapy
por: Jazirehi, Ali R.
Publicado: (2021)

Engineered T Cells for the Adoptive Therapy of B-Cell Chronic Lymphocytic Leukaemia
por: Koehler, Philipp, et al.
Publicado: (2012)

Adoptive Cell Therapies for Glioblastoma
por: Bielamowicz, Kevin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_p8h679n0c89jgdnl433s47s2av